Pharmacy Report Archives - Page 101 of 150 - Becker's Hospital Review

2nd COVID-19 shot safe despite allergic reactions to 1st: study | US News: No. 1 hospital by state | Pfizer, Moderna expand adolescent vaccine trials | CDC to revise masking guidance | Generic drug approvals falling

July 27, 2021 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 2nd vaccine dose safe despite allergic reactions to 1st, Mass General study finds Full story 2. FDA generic drug approvals falling, analysis finds Full story 3. Pfizer, Moderna expand vaccine trials…

Pfizer shot 39% effective against infection in Israel | Iowa may toss 38K expired COVID-19 shots | Why drug cross-contamination remains common | How giving pharmacists provider status affected patient care in Ohio

July 26, 2021 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Pfizer shot 39% effective against infection in Israel; 91% effective against severe disease Full story 2. Iowa may toss 38K expired COVID-19 vaccines by end of July Full…

Pfizer shot 88% effective against delta variant: study | Pharma companies reach $26B opioid deal | CDC: Benefits of J&J shot outweigh risks | Aduhelm has already generated $2M for Biogen

July 22, 2021 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Pfizer vaccine 88% effective against delta variant, UK study finds Full story 2. Pharma companies reach $26B civil opioid settlement Full story 3. Aduhelm has already generated $2M…

J&J shot may be less effective against delta variant | Banner joins 40 hospitals, groups mandating vaccines | Miss. pharmacist pleads guilty to $180M+ scheme | 2020 overdose deaths, by state | Insurers must cover PrEP at no cost

July 21, 2021 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. J&J shot may be significantly less effective against delta variant, small study hints Full story 2. Mississippi pharmacist pleads guilty to $180M+ insurance fraud scheme Full story 3.…

Pharma companies near $26B opioid settlement | 10 states with highest COVID-19 case increases | Pediatric prescriptions fell 27% in 2020 | Full FDA approval means more vaccine mandates: experts | What happened to Novavax's vaccine?

July 20, 2021 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. J&J, McKesson, Cardinal, AmerisourceBergen near $26B opioid settlement Full story 2. Pediatric prescriptions fell 27% in 2020, study finds Full story 3. Full FDA approval means more vaccine…

Pfizer shot gets FDA priority review | COVID-19 cases rising in all 50 states: 8 notes | Providence joins opposition to Aduhelm | EpiPen makers to pay $345M to settle price hike claims

July 19, 2021 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Pfizer COVID-19 shot to get FDA priority review Full story 2. Providence joins opposition to Aduhelm administration Full story 3. Kids under 12 could be eligible for COVID-19…

Cleveland Clinic, Mount Sinai won't administer Aduhelm | Mo. governor, Mercy execs clash over vaccine mandates | 10 costliest branded drugs in US | CDC panel to meet on vaccine boosters | Remdesivir may keep patients in hospital longer than needed: study

July 15, 2021 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Cleveland Clinic, Mount Sinai say they won't administer Aduhelm Full story 2. CDC vaccine panel to hold meeting on COVID-19 vaccine boosters Full story 3. 10 most expensive…

Drug overdose deaths up 30% in 2020 | 250 Intermountain workers affected by pharmacy closures | 6 BCBS affiliates won't cover Aduhelm | Biden nominates first physician as US drug czar | Mercy Health hospital pharmacy damaged in fire

July 14, 2021 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 'Terrifying': 2020 drug overdoses jump 30%, hit record 93,000 deaths Full story 2. 250 Intermountain employees affected by closing of 25 pharmacies Full story 3. Biden to nominate…

Pfizer needs more data on booster shots: regulators | COVID-19 cases up in 47 states | J&J shot may be linked to Guillain-Barré syndrome: FDA | Medicare begins reviewing Aduhelm coverage | Drugmakers spend more on stock buybacks, dividends than R&D

July 13, 2021 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Pfizer needs more data for COVID-19 booster shot approval, US regulators say Full story 2. Medicare begins process to determine Aduhelm coverage Full story 3. FDA to attach…

Pharma has 'mixed views' on Biden EO | Fauci: Full FDA approval for COVID-19 vaccines a technicality | Delta variant vs. vaccines: 5 notes | Aduhelm will likely cost patients $5K more than list price | 10 most, least stressed cities

July 12, 2021 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. The pharmaceutical industry has 'mixed views' on Biden's latest executive order Full story 2. Why Fauci thinks COVID-19 vaccines' full FDA approval is 'only a technical issue' Full…